<DOC>
	<DOCNO>NCT01251146</DOCNO>
	<brief_summary>This Phase 4 , prospective , multi-centric randomize control study compare effect bisoprolol atenolol rest heart rate ( RHR ) sympathetic nervous system 's ( SNS ) activity subject essential hypertension .</brief_summary>
	<brief_title>A Randomized Controlled Study Assess Effects Bisoprolol Atenolol Resting Heart Rate Sympathetic Nervous System 's Activity Subjects With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<criteria>Subjects age 2565 year Subjects essential hypertension ( EH ) Subjects systolic blood pressure ( SBP ) 140160 millimeter mercury ( mmHg ) diastolic blood pressure ( DBP ) 90100 mmHg Subjects normal sinus rhythm Subjects rest heart rate ( RHR ) great 70 bpm Subjects give write informed consent Subjects atrial fibrillation ( AF ) /sick sinus syndrome ( SSS ) /atrioventricular block IIIII Grade ( AVB IIIII ) without pacemaker Subjects bradyarrhythmia/hypotension Subjects unstable angina pectoris ( UAP ) /acute myocardial infarction ( AMI ) /heart failure ( HF ) ( New York Heart Association [ NYHA ] Class III IV ) Subjects uncontrolled diabetes mellitus ( DM ) Subjects bronchial asthma Subjects gastrointestinal ulcer skin ulcer Subjects liver dysfunction/renal impairment Subjects treat calcium channel blocker ( except amlodipine ) betablockers . Subjects glaucoma Subjects know allergic/intolerance betablocker Pregnant lactate woman Subjects participate another clinical study within last 3 month Subjects legal incapacity limited legal capacity</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Bisoprolol</keyword>
	<keyword>Atenolol</keyword>
</DOC>